Stock Market News

2 months Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly’s Obesity Triplet Investor's Business Daily

Viking Therapeutics stock ramped higher Thursday after the company outlined its weight-loss quad — a blow to Eli Lilly’s experimental triple.
The post Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly's Obesity Triplet appeared firs…

Eli Lilly (LLY)

1 day Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks

2 days Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance

3 days Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks

3 days Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks

3 days Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance

3 days Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance

5 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance

5 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily

5 days Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance

6 days Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube

6 days Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com

6 days There’s a New Obesity King The Wall Street Journal

6 days Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha

6 days LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks

6 days FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com

6 days Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch

7 days Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com

7 days IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily

7 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC

7 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha

1 week Eli Lilly’s Alzheimer’s treatment approved in China Investing.com

1 week Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com

1 week Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks

1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

1 week 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance

1 week Eli Lilly: A Rare Buying Opportunity Seeking Alpha

1 week Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily

1 week EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks

2 weeks Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com

2 weeks Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks

2 weeks Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance

2 weeks Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

2 weeks Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC

2 weeks Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube

2 weeks Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com

2 weeks Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com

2 weeks Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks

2 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

2 weeks Eli Lilly announces $15 billion buyback, dividend hike Investing.com

2 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

2 weeks Netflix, Eli Lilly among Monday’s market cap stock movers Investing.com

2 weeks Eli Lilly Stock Just Got Even Sweeter. Here’s Why It’s Worth Buying Now Yahoo Finance

2 weeks The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

3 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks

3 weeks Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks

3 weeks How to Play LLY Stock as Zepbound Beats NVO’s Wegovy in Obesity Study Zacks

3 weeks Eli Lilly Chief Scientific Officer explains Zepbound’s weight loss advantage YouTube

3 weeks Prescription fills for weight loss drugs Zepbound, Wegovy more than doubled in 2024, GoodRx says CNBC

3 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily

3 weeks LLY’s Zepbound Outshines NVO’s Wegovy in Head-to-Head Obesity Study Zacks

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.